Overall, these data strongly suggest that the NKG2D/NKG2D-L and TNFRSF14/CD160 pathways play a prominent role in the immune surveillance of BLCA tumors by IL-2-expanded NK cells. Here, CD160 is linked to bladder transitional cell carcinoma.